Yiming Liu specializes in representing companies and investment funds with mergers and acquisitions and other strategic transactions across multiple industries, including life sciences and high-tech industries. He is uniquely positioned to leverage his technical background—with advanced degrees in molecular, cellular and developmental biology and health services administration—to help clients achieve results that make practical and commercial sense. On behalf of clients in the United States, Europe and China, he has successfully led the structuring, negotiation and documentation of a wide range of cross-border transactions involving critical intellectual property, including mergers and acquisitions, private financings, joint ventures, research collaborations and licensing arrangements.
In addition to his track record executing complex corporate and commercial transactions, Yiming is also recognized for his work on life sciences and high-tech IPOs and other public market transactions in Hong Kong and the United States, experience which is invaluable for both public company clients and clients considering an initial public offering.
Prior to joining O’Melveny, Yiming practiced in the New York and Shanghai offices of two other leading U.S. law firms.
Languages
Admissions
Education
- Columbia University, J.D.
- University of Michigan, M.S. (Molecular, Cellular, and Developmental Biology); M.H.S.A. (Health Services Administration)
- Fudan University, B.S. (Biological Sciences)